Form 4: Rockwell Medical CEO Mark Strobeck Reports Tax-Related Stock Disposal

Sentiment:

SEC Form 4 Filing


Mark Strobeck, CEO of Rockwell Medical, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Summary

  • On March 17, 2024, Mark Strobeck, the President and CEO of Rockwell Medical, Inc. (RMTI), disposed of 6,101 shares of common stock to cover tax withholding obligations.
  • The shares were withheld from the vesting of restricted stock units.
  • Following the transaction, Strobeck directly owns 149,364 shares of Rockwell Medical common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider transactions for tax purposes, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and tax obligations. It's common for executives to have shares withheld to cover taxes when restricted stock units vest.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.

Key Dates

DateDescription
03/17/2024Date of stock disposal transaction.
03/19/2024Date of signature for the SEC Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.